Braun J - Search Results

1

The high prevalence of infections and allergic symptoms in patients with ankylosing spondylitis is associated with clinical symptoms.

Zochling J, Bohl-Bühler MH, Baraliakos X, Feldtkeller E, Braun J. Zochling J, et al. Among authors: braun j. Clin Rheumatol. 2006 Sep;25(5):648-58. doi: 10.1007/s10067-005-0130-0. Epub 2005 Dec 23. Clin Rheumatol. 2006. PMID: 16374575

2

Prevalence of spondyloarthropathy in Japan.

Feldtkeller E, Braun J. Feldtkeller E, et al. Among authors: braun j. J Rheumatol. 2002 May;29(5):1105-7; author reply 1107. J Rheumatol. 2002. PMID: 12022334 No abstract available.

3

Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis.

Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J. Feldtkeller E, et al. Among authors: braun j. Rheumatol Int. 2003 Mar;23(2):61-6. doi: 10.1007/s00296-002-0237-4. Epub 2002 Sep 3. Rheumatol Int. 2003. PMID: 12634937

4

Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept.

Brandt J, Khariouzov A, Listing J, Haibel H, Sörensen H, Rudwaleit M, Sieper J, Braun J. Brandt J, et al. Among authors: braun j. J Rheumatol. 2004 Mar;31(3):531-8. J Rheumatol. 2004. PMID: 14994401 Clinical Trial.

5

Management and treatment of ankylosing spondylitis.

Zochling J, Braun J. Zochling J, et al. Among authors: braun j. Curr Opin Rheumatol. 2005 Jul;17(4):418-25. doi: 10.1097/01.bor.0000163194.48723.64. Curr Opin Rheumatol. 2005. PMID: 15956838 Review.

6

Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept.

Davis JC Jr, Van der Heijde DM, Dougados M, Braun J, Cush JJ, Clegg DO, Inman RD, de Vries T, Tsuji WH. Davis JC Jr, et al. Among authors: braun j. J Rheumatol. 2005 Sep;32(9):1751-4. J Rheumatol. 2005. PMID: 16142873 Clinical Trial.

7

Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary?

Hermann KG, Landewé RB, Braun J, van der Heijde DM. Hermann KG, et al. Among authors: braun j. J Rheumatol. 2005 Oct;32(10):2056-60. J Rheumatol. 2005. PMID: 16206370

8

Magnetic resonance imaging in spondyloarthropathies.

Baraliakos X, Braun J. Baraliakos X, et al. Among authors: braun j. Joint Bone Spine. 2006 Jan;73(1):1-3. doi: 10.1016/j.jbspin.2005.09.003. Epub 2005 Dec 1. Joint Bone Spine. 2006. PMID: 16414300 No abstract available.

9

Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis--a population-based survey.

Zochling J, Bohl-Bühler MH, Baraliakos X, Feldtkeller E, Braun J. Zochling J, et al. Among authors: braun j. Clin Rheumatol. 2006 Nov;25(6):794-800. doi: 10.1007/s10067-005-0132-y. Epub 2006 Mar 10. Clin Rheumatol. 2006. PMID: 16528455

10

Systematic review of measures and their concepts used in published studies focusing on the treatment of acute inflammatory arthritis.

Zochling J, Bonjean M, Grill E, Scheuringer M, Stucki G, Braun J. Zochling J, et al. Among authors: braun j. Clin Rheumatol. 2006 Nov;25(6):807-13. doi: 10.1007/s10067-005-0156-3. Epub 2006 Apr 22. Clin Rheumatol. 2006. PMID: 16633711 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,483 results

Search Page